SP1
Click for more information
0.00% $1.07 southern cross payments ltd

Ann: Appendix 4E and 2019 Annual Report, page-61

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
  1. aniesbaswedan
    6,681 Posts.
    lightbulb Created with Sketch. 1545
    clock Created with Sketch.
    28/02/20
    21:19
    Post #: 43226524
    The reason? The reason is quite clear...

    https://hotcopper.com.au/data/attachments/2014/2014459-84f9979a8d128705c52e895d6b032e6b.jpg
    Suspected contravention..........I think Grant Thornton is being euphimistic here in their wording too.

    Feel free for all holders to direct their anger to ASIC now...not going to dig dirt on ASIC investigators? Is ISX also a potential competitor to ASIC? LOL!
    Last edited by aniesbaswedan: 28/02/20
    ISX Price at posting: $1.07 Sentiment: None Disclosure: Not Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Drilling to kick off at high-priority Bara Creek Prospect, targeting a promising epithermal system near the Bowdens Silver Project
right-arrow Created with Sketch.
NEWS High-grade rare earth and titanium discoveries confirmed from maiden RC drilling at Mata da Corda, highlighting significant exploration potential
right-arrow Created with Sketch.
NEWS Full funding secured for Pular lithium project development: joint venture nears completion
right-arrow Created with Sketch.
NEWS High-grade rock chip assays from Titan surface sampling exceed 55% gold and 1,000 g/t silver, unlocking significant exploration potential at this promising prospect
right-arrow Created with Sketch.
NEWS New gold and silver soil anomalies uncovered at Black Range, strengthening exploration potential
right-arrow Created with Sketch.
RCE Phase II clinical trial recruitment for R327G topical gel passes halfway, showing promising results against bacterial skin infections
right-arrow Created with Sketch.
watchlist Created with Sketch. Add SP1 (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.